Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Amperozide
1. Amperozide Hcl
2. Hogpax
3. 86725-37-3
4. Amperozide Hydrochloride [mi]
5. 75529-73-6
6. 4-[4,4-bis(4-fluorophenyl)butyl]-n-ethylpiperazine-1-carboxamide;hydrochloride
7. 8v2171u69n
8. Ncgc00093556-01
9. 4-[4,4-bis(4-fluorophenyl)butyl]-n-ethyl-1-piperazinecarboxamide Hydrochloride
10. Dsstox_cid_25750
11. Dsstox_rid_81094
12. Dsstox_gsid_45750
13. 4-(4,4-bis(p-fluorophenyl)butyl)-n-ethyl-1-piperazinecarboxamide Hydrochloride
14. Cas-75529-73-6
15. Fg 5606
16. Fg-5606
17. Unii-8v2171u69n
18. Amperozide Hydrochloride [who-dd]
19. Amperozide Monohydrochloride
20. Mls002153519
21. Schembl1321270
22. Amperozide Hydrochloride (1:1)
23. Chembl1257106
24. Chebi:180485
25. Dtxsid501019079
26. Tox21_111208
27. Tox21_500040
28. Akos024457273
29. Tox21_111208_1
30. Lp00040
31. 4-[4,4-bis(4-fluorophenyl)butyl]-n-ethylpiperazine-1-carboxamide Hydrochloride
32. Ncgc00015081-04
33. Ncgc00260725-01
34. As-16836
35. Smr001230851
36. Eu-0100040
37. A 6976
38. Sr-01000076207
39. Sr-01000076207-1
40. Q27271058
41. 1-[4,4-bis(4-fluorophenyl)butyl]-4-(ethylcarbamoyl)piperazin-1-ium Chloride
42. 1-piperazinecarboxamide, 4-(4,4-bis(4-fluorophenyl)butyl)-n-ethyl-, Hydrochloride (1:?)
| Molecular Weight | 438.0 g/mol |
|---|---|
| Molecular Formula | C23H30ClF2N3O |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 7 |
| Exact Mass | 437.2045466 g/mol |
| Monoisotopic Mass | 437.2045466 g/mol |
| Topological Polar Surface Area | 35.6 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 461 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Psychotropic Drugs
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)
ABOUT THIS PAGE
84
PharmaCompass offers a list of Amperozide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amperozide manufacturer or Amperozide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amperozide manufacturer or Amperozide supplier.
PharmaCompass also assists you with knowing the Amperozide API Price utilized in the formulation of products. Amperozide API Price is not always fixed or binding as the Amperozide Price is obtained through a variety of data sources. The Amperozide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Amperozide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amperozide, including repackagers and relabelers. The FDA regulates Amperozide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amperozide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Amperozide supplier is an individual or a company that provides Amperozide active pharmaceutical ingredient (API) or Amperozide finished formulations upon request. The Amperozide suppliers may include Amperozide API manufacturers, exporters, distributors and traders.
Amperozide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amperozide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amperozide GMP manufacturer or Amperozide GMP API supplier for your needs.
A Amperozide CoA (Certificate of Analysis) is a formal document that attests to Amperozide's compliance with Amperozide specifications and serves as a tool for batch-level quality control.
Amperozide CoA mostly includes findings from lab analyses of a specific batch. For each Amperozide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amperozide may be tested according to a variety of international standards, such as European Pharmacopoeia (Amperozide EP), Amperozide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amperozide USP).
